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Abstract 1
The emergence of antibiotic resistance in human pathogens has become a major threat 2 to modern medicine and in particular hospitalized patients. The outcome of antibiotic 3 treatment can be affected by the composition of the gut resistome either by enabling 4 resistance gene acquisition of infecting pathogens or by modulating the collateral 5 effects of antibiotic treatment on the commensal microbiome. Accordingly, 6 knowledge of the gut resistome composition could enable more effective and 7 individualized treatment of bacterial infections. Yet, rapid workflows for resistome 8 characterization are lacking. To address this challenge we developed the poreFUME 9 workflow that deploys functional metagenomic selections and nanopore sequencing to 10 resistome mapping. We demonstrate the approach by functionally characterizing the 11 gut resistome of an ICU patient. The accuracy of the poreFUME pipeline is >97 % 12 sufficient for the reliable annotation of antibiotic resistance genes. The poreFUME 13 pipeline provides a promising approach for efficient resistome profiling that could 14 inform antibiotic treatment decisions in the future. It is estimated that every year 700,000 people die of resistant infections [1] . Antibiotic 20 resistance by human pathogens has become a major threat, in particular for 21 hospitalized patients [1, 2] . Bacterial infections by resistant pathogens are also 22 coupled with an increase in healthcare costs [3] . The gut microbiome comprises a 23 diverse set of antibiotic resistance genes which may impact antibiotic treatment 24 3 outcomes in at least two ways [4] [5] [6] . First, the gut microbiome can act as a reservoir of 25 resistance genes that can be acquired by infecting human pathogens leading to 26 evolution of resistance during infection. Indeed, a close evolutionary relationship 27 between resistance genes in pathogens and commensals has been found [7] . Second, 28 the gut resistome impacts the extent to which the commensal microbiota is affected by 29 antibiotic treatment. Studies of preterm infants and their response to antibiotic 30 treatment suggest that the collateral damage to the commensal microbiota can be 31 predicted from the resistome status at the start of treatment [8] . Accordingly, there is 32 an increasing interest in the development of clinically applicable workflows that 33 enable expedited and comprehensive characterization of the gut resistome. 34 Unfortunately, given the diversity of antibiotic resistance genes in the gut microbiota, 35 sequencing based methods alone cannot enable a representative characterization of the 36 gut resistome. Instead, functional metagenomic selections, which circumvent the 37 culturing step of individual gut microbes, allow less biased interrogation of the gut 38 resistome [9] . Consequently, rapid resistome profiling using a functional-metagenomic 39 approach would be a viable approach to guide personalized antibiotic treatment. sequencing data was obtained using Sanger sequencing, [11, 12] In this study we developed the poreFUME workflow to characterize the resistome of a 78 clinical samples ( Figure 1 ) using nanopore sequencing. Metagenomic expression 79 libraries were constructed using fecal samples from a hospitalized patient as input. 80 The libraries were selected on solid media containing various antibiotics and DNA 81 was extracted from the surviving clones expressing metagenomic inserts conferring 82 antibiotic resistance. The extracted DNA was sequenced using nanopore sequencing. 83 Finally the sequence data was processed using the poreFUME computational pipeline 84 which demultiplexes the barcodes, increases the data quality and annotates antibiotic 85 resistance genes. 
Results

98
We constructed a metagenomic expression libraries from fecal samples obtained from 99 an Intensive Care Unit (ICU) patient as described in [23] (Materials and methods). 100 The library size ranged between 2.9 -8.8 x 10 8 bp of DNA ( Supplementary table 1 ).
101
The metagenomic libraries were plated on solid agar media containing inhibitory 102 6 concentrations of the antibiotics: tobramycin, spectinomycin, ampicillin, cefotaxime, 103 azithromycin, tetracycline or fosfomycin ( Supplementary table 2 ). Clones from the 104 metagenomic libraries able to tolerate each of these seven different antibiotics were 105 detected in all libraries ( Supplementary table 2 ). From each antibiotic plate a 106 representative number of clones were selected (in total 864), pooled, barcoded using 107 PCR and prepared for sequencing using the MinION nanopore sequencer (Materials 108 and methods). The first step of poreFUME is to demultiplex the barcodes. We identified all the 39 119 experimentally attached barcodes in both the nanopore sequencing libraries (Figure 2 ).
120
The abundance showed a significant correlation of log transformed abundance with 121 the Pearson correlation test (R 2 = 0.75 , p< 10 -12 ) between the two libraries, 122 highlighting the reproducibility of the sequencing and barcode demultiplexing step. 
129
The sequencing data obtained with MinION nanopore R7 chemistry has an 2D read 130 accuracy of ~85% [21] . This relative high error rate can be mitigated using error 131 correction, with tools such as nanocorrect [21] . Nanocorrect is implemented as second 132 step in the poreFUME pipeline. Nanocorrect has been applied previously to increase 133 the nanopore read accuracy from 80.5% to 95.9% [21] . The algorithm identifies 134 overlapping reads using DALIGNER [24] and calculates a consensus sequence, using 135 partial-order alignment (POA) software [25] . Two rounds of error correction where 136 conducted by the poreFUME pipeline. To validate the nanopore sequencing results, we sequenced the same barcoded DNA 149 using PacBio SMRT technology yielding 93.5 Mbase of DNA in 68,144 reads (with 150 8 >99% accuracy) from two sequencing cells. After annotation with the CARD 151 database, we observed that the exact same set of 26 antibiotic resistance genes 152 detected in the nanopore dataset were also present in the PacBio dataset (Figure 4 ).
153
The mean sequence identity of the genes identified in the CARD database is for the 154 PacBio dataset with 97.8% slightly better then that of the nanopore dataset with 155 97.2% (Supplementary Figure 2) . The abundance of reads between the nanopore and Nanopore reads are longer and typically capture the entire metagenomic insert. In this 181 way analysis of the context of the antibiotic resistance gene is simplified. As an 182 example to link genotype and phenotype we investigated the 244 nanopore reads that 183 were selected on plates containing spectinomycin and resulted in a CARD annotation. 184 All the 244 reads contain the aadA gene which encodes an aminoglycoside 185 nucleotidyltransferase known to confer resistance to spectinomycin (Figure 6a ). In 74 186 reads aadA was flanked by sat-1 which encodes a streptothricin acetyltransferase and 187 confers resistance to streptothricin, again sat-1 is likely to be co-selected with aadA. 188 In 44 reads the aadA was the only gene detected, however in 126 reads aadA was 189 flanked by dfrA1. The dfrA1 gene confers resistance to trimethoprim and is not known 190 to confer resistance to spectinomycin. Alignment of the longest nanopore read 191 containing both dfrA1 and aadA against the NT database showed that the two highest 192 scoring hits are part of an integron class I (Figure 6b ). Nanopore sequencing is thus HQ132378.1) and the E. coli plasmid pH1038-142 (genbank: KJ484634) Hospital settings, including ICUs, are hotspots for the emergence and selection for 214 antibiotic resistant organisms. In this study we successfully applied nanopore 215 sequencing to characterize the gut resistome of an ICU patient using metagenomic 216 functional selections. Nanopore sequencing is known to have a higher error rate 217 compared to other sequencing technologies; however, implementing a double error 218 correction scheme in poreFUME we achieve accuracies above 97%, which enables 219 reliable resistance gene annotation and comparable results to that of PacBio SMRT 220 sequencing. In this study both sequencing platforms enabled the reliable identification 221 of 26 unique antibiotic resistance genes. This, along with the rapid turnaround time of 222 the poreFUME workflow, suggests that it could be applied as a possible resistome 223 monitoring tool. In conclusion, the poreFUME pipeline provides a promising alternative to other next-234 generation sequencing alternatives [6, 15] and can be used to rapidly profile the 235 resistome of both environmental and gut microbial communities [4] [5] [6] . We foresee 236 that rapid resistome profiling tools such as poreFUME could aid the implementation 237 of personalized antibiotic treatment in high risk patients. The clones from the individual square agar plates were collected by adding 5 ml dH 2 0 314 and scraped off with an L-shaped cell scraper. The washing step was repeated twice to 315 remove all the cells from the plate. The bacterial cells were then pelleted by 316 centrifugation at 5.000 rpm x g for 10 min. The supernatant was discarded and the 317 pellet was dissolved in 10 ml of dH 2 O. Two ml of the collected bacterial cells was 318 used for plasmid extractions with the Plasmid Mini Kit (Invitrogen). The rest of the 319 cells were heat inactivated at 95 °C for 10 min and stored as raw bacterial cell pellet. 320 For nanopore and PacBio sequencing, primers were synthetized that amplify the 321 common region on pZE21-MCS-together with the specific barcodes from PacBio 322 (Supplementary table 5). One ng of DNA or 1 µl of raw bacterial cell pellet was 323 amplified by PCR.
Amplified and barcoded DNA was size selected by 324 electrophoresis. Agarose gel slices selected from the size range 1 -5 kb were purified 325 using Gel Purification Kit (Fermentas). In total 39 barcodes (1 and 11-48) were 326 multiplexed.
327
Nanopore sequencing library preparation 328
The nanopore sequencing library B was prepared during poreCamp as briefly 329 described below. DNA QC was performed using Qubit dsDNA High Sensitivity 
